These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36822359)

  • 1. Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: Patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09).
    Lee TH; Shin H; Ahn YC; Kang MK; Song C; Kim WC; Moon SH; Kim JH; Cho J; Park HJ; Lee HK; Kim BH; Kim HJ
    Radiother Oncol; 2023 Jun; 183():109572. PubMed ID: 36822359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitive radiotherapy for hilar and/or mediastinal lymph node metastases after stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer: 5-year results.
    Manabe Y; Shibamoto Y; Baba F; Yanagi T; Iwata H; Miyakawa A; Murai T; Okuda K
    Jpn J Radiol; 2018 Dec; 36(12):719-725. PubMed ID: 30218253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    Verma V; Schonewolf CA; Cushman TR; Post CM; Doms A; Berman AT; DeVries M; Katz SI; Simone CB
    Clin Lung Cancer; 2018 Nov; 19(6):502-510. PubMed ID: 30111509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer : An investigation of 117 pelvic lymph nodes.
    Cozzi S; Botti A; Timon G; Blandino G; Najafi M; Manicone M; Bardoscia L; Ruggieri MP; Ciammella P; Iotti C
    Strahlenther Onkol; 2022 Aug; 198(8):700-709. PubMed ID: 34757443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer.
    Meng MB; Wang HH; Zaorsky NG; Zhao XZ; Wu ZQ; Jiang B; Song YC; Zhuang HQ; Li FT; Zhao LJ; Wang CL; Li K; Wang P; Yuan ZY
    Oncotarget; 2015 Jun; 6(17):15690-703. PubMed ID: 25881546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients.
    Yamashita H; Jingu K; Niibe Y; Katsui K; Matsumoto T; Nishina T; Terahara A
    Radiat Oncol; 2017 Feb; 12(1):38. PubMed ID: 28219406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage radiotherapy for regional lymph node oligo-recurrence after radical surgery of non-small cell lung cancer.
    Seol KH; Lee JE; Cho JY; Lee DH; Seok Y; Kang MK
    Thorac Cancer; 2017 Nov; 8(6):620-629. PubMed ID: 28906073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience.
    Oehler C; Zimmermann M; Adam L; Curschmann J; Sumila M; Strebel RT; Cathomas R; Li Q; Schneider U; Zwahlen DR
    BMC Urol; 2019 Sep; 19(1):84. PubMed ID: 31500621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
    Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
    Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated Nodal Failure after Stereotactic Body Radiotherapy for Lung Cancer: The Role for Salvage Mediastinal Radiotherapy.
    Ward MC; Oh SC; Pham YD; Woody NM; Marwaha G; Videtic GM; Stephans KL
    J Thorac Oncol; 2016 Sep; 11(9):1558-64. PubMed ID: 27223455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy.
    Kim D; Kim DY; Kim JS; Hong SK; Byun SS; Lee SE
    PLoS One; 2021; 16(9):e0256778. PubMed ID: 34506516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
    Cozzi S; Alì E; Bardoscia L; Najafi M; Botti A; Blandino G; Giaccherini L; Ruggieri MP; Augugliaro M; Iori F; Sardaro A; Iotti C; Ciammella P
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
    Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY
    J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
    Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
    Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers.
    Horne ZD; Richman AH; Dohopolski MJ; Clump DA; Burton SA; Heron DE
    Lung Cancer; 2018 Jan; 115():1-4. PubMed ID: 29290248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group.
    Giuliani ME; Hope A; Mangona V; Guckenberger M; Mantel F; Peulen H; Sonke JJ; Belderbos J; Werner-Wasik M; Ye H; Grills IS
    Clin Lung Cancer; 2017 Mar; 18(2):162-168. PubMed ID: 27876604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
    Ito M; Kodaira T; Koide Y; Okuda T; Mizumatsu S; Oshima Y; Takeuchi A; Mori T; Abe S; Asai A; Suzuki K
    BMC Cancer; 2020 Jun; 20(1):540. PubMed ID: 32517673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.